Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLINICA 100 TOP 10: Siemens Healthcare

This article was originally published in Clinica

Executive Summary

Siemens Healthcare is a non-mover, staying at No 4 in our Clinica 100 league table. It is No 3 in our IVD list and No 2 in Imaging list (as our cut-of date is June 30, 2015*, we have taken Siemens’ figures from fiscal 2014 ending Sept 30, 2014). 2014 marked a year of major streamlining for Siemens as it focuses on its higher-growth, higher margin business. It divested its audiology business to private equity firm EQT in November that year, sold off its health IT business unit to Cerner in August and its microbiology diagnostic unit to Danaher in July. The three deals brought in significant cash for Siemens, with a total value of over $4.42bn.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103072

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel